• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Hidden data on obesity prospect wipe $12B off Amgen market cap

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 13, 2024 at 11:22: AM
via A hidden tab in an Excel spreadsheet published nine months ago has wiped $12 billion off Amgen’s market cap. The tab contains data on bone density changes in patients who received Amgen’s obesity prospect MariTide in a phase 1 trial.

article source
 




Top Bottom
Back
Quote